A young British woman who used to drink 12 cups of coffee a day and quit because of some caffeine withdrawal symptoms like severe headaches was diagnosed with grade three oligodendroglioma—a type of ...
Ultimately, Chimerix’s board went with Jazz’s offer due to its cash payable nature and the recent downward trend in biopharma ...
New Drug Application (NDA) for Dordaviprone as Treatment for Recurrent H3 K27M-Mutant Diffuse Glioma Under Review with Prescription Drug User Fee Act (PDUFA) Action Date of August 18, 2025 Acquisition ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...
Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage biotechnology company at the forefront of research and development of innovative tr ...
Mount Sinai scientists will continue studying PGV001 in larger groups of patients and testing how it works with other cancer treatments. Data from this phase 1 study have prompted three additional ...
The PSMA-PET imaging agent will be used for patients who have suspected metastasis and those with suspected cancer recurrence.
Researchers at the University of Tsukuba have investigated the changes in the primary evaluation items in phase II clinical ...
News Medical on MSN9h
Groundbreaking study unveils key mechanism for neuronal identity regulationA team of researchers from the Institute for Neurosciences, a joint center of the Spanish National Research Council (CSIC) and the Miguel Hernández University (UMH) of Elche, in collaboration with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback